Farmak JSC, the leading manufacturer of neurological and endocrinologic drugs in Ukraine, has developed and launched on the market a new antiepileptic drug, Meditan® (active ingredient: gabapentin) that comes in capsules.
Meditan® is intended for treatment of partial epileptic seizures with or without secondary generalization in adults and children (in combination with other antiepileptic drugs for children over 6 or as a monotherapy for children over 12). The new drug may also be used for treatment of associated nerve pain in adults with diabetic neuropathy and postherpetic neuralgia.
